openPR Logo
Press release

Self-administered HPV Test Market Size, Segmentation, Drivers, Challenges, Key Regions Analysis (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa) Report, Reviewed by 2018-26

07-24-2018 02:57 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

Fact.MR

Fact.MR

Growing prevalence of the sexually transmitted diseases and increase in the cervical cancer cases in women aged above 30 years are the driving factors of the self-administered HPV test market. Novel healthcare self-administered HPV kits have been designed which allow women to self-screen the samples. This self-administered test is easy to perform and it is relatively cheap compared to the conventional test. These factors are expected to boost up the self-administered  HPV test market Moreover, Self-sampling is less invasive, requires less time to perform as well as it allows for privacy and reduces pain and discomfort among women rising up the self-administered HPV test market. Self-administered HPV test can be used in fewer resource areas where women are underscreened or never screened and where chances of cervical cancer are very high increases the demand of self-administered HPV test kits in such regions. The self-administered HPV test is less specific as compared to the conventional cytological test adds to the limitation of self-administered HPV test market. Less adoption of such self-administered kits by the healthcare professional as well as by the women limit the overall growth of the market. Additionally, the individual performing the self-administered test should be knowledgeable and should perform and collect the sample with high efficacy. These factors add up the limitation of self-administered HPV test market in low healthcare facilities areas. Cultural sensitivity issues in rural areas also limit the self-administered HPV test market.

Request Brochure of this Report@ https://www.factmr.com/connectus/sample?flag=B&rep_id=1150

Based on the technology, Self-administered HPV test kit is segmented into:

DNA based assays
Hybrid capture 2
Cervista HPV HR
Cervista HPV 16/18 tests
Cobas 4800 HPV
RNA based assays
APTIMA HPV Assay
Based on disease indications, self-administered HPV test is segmented into:

Cervical cancer
Vaginal cancer
Based on end users, self-administered HPV test is segmented into:

Clinics
Home-based settings
Healthcare centers
Diagnostic centers
Though significant research has been done in preventing cancer, it continues to cause the mortality and morbidity among women. Self-administered HPV test helps to decline the death rate due to cervical cancer. This test is effective for women who are not accessing the routine screening. CareHPV sample collection and test kits by QIAGEN are suitable self-collected kits which can be used in low-resource settings and the samples can be stored at room temperature for about 14 days. Overall the rise in the self-administered HPV test kit market is increasing in developed countries where women are aware of the cervical and vaginal cancers. Self-administered HPV test market is expected to grow in the overall forecast period.

Request TOC of this Report@ https://www.factmr.com/connectus/sample?flag=B&rep_id=1150

Based on geography, mortuary equipment market is segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is the dominant market of self-administered HPV test kits due to increase in death of women by cervical cancer. This is followed by Europe because of high healthcare facilities. Asia Pacific has also fueled the market of self-administered HPV kits due to increase in the awareness among women. Overall the demand for self-administered HPV test kit is high because of the high prevalence of HPV related diseases.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size Analysis
Current Trends/Issues/Challenges
Competition & Companies involved
Value Chain Analysis
The regional analysis includes:

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
Eastern Europe (Poland, Russia)
Asia-Pacific Excluding China and Japan (India, ASEAN, Australia & New Zealand)
China
Japan
The Middle East and Africa (GCC, S. Africa, N. Africa)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Ask our Industry Expert on this Report@ https://www.factmr.com/connectus/sample?flag=AE&rep_id=1150

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Follow Us on Linkedin: https://www.linkedin.com/company/factmr/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Self-administered HPV Test Market Size, Segmentation, Drivers, Challenges, Key Regions Analysis (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa) Report, Reviewed by 2018-26 here

News-ID: 1143362 • Views:

More Releases from Fact.MR

Vegan Flavors Market Is Slated To Reach US$ 18,324.3 Million At A CAGR Of 5.2% B …
The global vegan flavor market is estimated to be valued at US$ 11,078.2 million in 2024 and is forecast to reach a value of US$ 18,324.3 million by 2034, with a projected CAGR of 5.2% from 2024 to 2034 owing to the rising popularity of plant-based diets. The Vegan Flavor Industry sales study offers a comprehensive analysis on diverse features including production capacities, Vegan Flavor demand, product developments, sales revenue generation
Pesticide Inert Ingredients Market Is Projected To Reach A Value Of US$ 13,167.2 Million By 2034: Fact.MR Report
Pesticide Inert Ingredients Market Is Projected To Reach A Value Of US$ 13,167.2 …
The global pesticide inert ingredients market is estimated to attain a valuation of US$ 7,621.2 million in 2024. During the forecast period, 2024-2034, the demand for pesticide-inert ingredients is expected to advance at a 5.6% CAGR globally. By 2034, the industry is expected to have grown to a valuation of US$ 13,167.2 million in size. The Pesticide Inert Ingredients Industry sales study offers a comprehensive analysis on diverse features including production
Portable Bluetooth Speaker Market Is Projected To Reach A Value Of US$ 20,521 Million At A CAGR Of 10.6% By 2034
Portable Bluetooth Speaker Market Is Projected To Reach A Value Of US$ 20,521 Mi …
The global portable bluetooth speaker market is estimated to be valued at US$ 7,521.6 million in 2024. The market is anticipated to reach US$ 20,521 million by 2034, with a projected CAGR of 10.6% from 2024 to 2034. The Portable Bluetooth Speaker Industry sales study offers a comprehensive analysis on diverse features including production capacities, Portable Bluetooth Speaker demand, product developments, sales revenue generation and Portable Bluetooth Speaker market outlook
Atrial Fibrillation Device Market to Attain US$ 24.76 Billion at 14.3% CAGR by 2034: Fact.MR Report
03-29-2024 | Health & Medicine
Fact.MR
Atrial Fibrillation Device Market to Attain US$ 24.76 Billion at 14.3% CAGR by 2 …
The global atrial fibrillation devices market (心房細動装置市場) size stands at a valuation of US$ 6.52 billion in 2024, with forecasts predicting a surge to US$ 24.76 billion by the conclusion of 2034. Sales of atrial fibrillation devices worldwide are expected to witness an impressive compound annual growth rate (CAGR) of 14.3% from 2024 to 2034. In recent years, the global healthcare landscape has witnessed a significant surge in the prevalence of

All 5 Releases


More Releases for HPV

Human Papillomavirus (HPV) Vaccines Market is Thriving Worldwide with Top Compan …
Los Angeles, United State, –The report titled Global Human Papillomavirus (HPV) Vaccines Market is one of the most comprehensive and important additions to QY Research’s archive of market research studies. It offers detailed research and analysis of key aspects of the global Human Papillomavirus (HPV) Vaccines market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete
HPV Vaccines Market 2020-2026 - COVID19 Impact On HPV Vaccines Industry | Top Ke …
HPV Vaccines Market Size, Share & Industry Analysis, By Type (Bivalent and Polyvalent), By Disease Indication (HPV Associated Cancer and Genital Warts), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, and Others) and Geography Forecast, 2019-2026. Get Sample Copy Of Report To Know The Impact of Covid19 on this Industry: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/human-papillomavirus-hpv-vaccines-market-101962 Top Key Players: GSK, Merck. An Overview of the Impact of COVID-19 on HPV Vaccines Market: The emergence of COVID-19 has brought
HPV Testing & PAP Test Market by Test Type (HPV Testing, Follow-up HPV Testing, …
Global HPV Testing & PAP Test Market was valued at USD XX billion in the year 2017. Global HPV Testing & PAP Test market is further estimated to grow at a CAGR of XX % from 2018 to reach USD XX billion by the year 2023. Get Free Access to Sample Report @ https://genesismarketinsights.com/Sample_Request/GENRE385 In the Global HPV Testing & PAP Test Market, by region, North America holds the highest market share
Human Papillomavirus (HPV) Therapeutics Market to Reach US$2.34 bn by 2020, Driv …
Human papillomavirus (HPV) and cytomegalovirus (CMV) are viral pathogens affecting individuals of all ages. HPV causes serious sexually transmitted diseases (STDs), while CMV is an opportunistic pathogen affecting immunocompromised individuals such as HIV patients. The global market for HPV and CMV therapeutics is expected to experience a surge due to various macro and micro economic factors. Read the Comprehensive Overview of Human Papillomavirus (HPV) Therapeutics Market:
Cytology and HPV Testing Market: Disparate Levels of Awareness among Patients Re …
Over the years, the level of awareness among the global population regarding the various types of cancer has increased tremendously. The significance of early detection and diagnosis is not lost on them, resulting in the increased adoption of screening tests such as cytology and human papillomavirus (HPV) testing. The global market for cytology and HPV testing is presented with a host of sustained growth opportunities arising mainly from several emerging economies,
New Research: Global Human Papillomavirus (HPV) Market
MarketResearchReports.Biz presents this most up-to-date research on "Human Papillomavirus (HPV)- Epidemiology Forecast To 2023" Latest Report, Human Papillomavirus (HPV) - Epidemiology Forecast To 2023 provides an overview of the epidemiology trends of Human Papillomavirus (HPV) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Human Papillomavirus (HPV) prevalent or incident cases segmented by age, sex and subpopulations. The